E-Z-EM launches new blood analyser:
This article was originally published in Clinica
Executive Summary
E-Z-EM, of Lake Success, New York, has formally launched its EZ CHEM blood analyser, a convenient point-of-care blood assay device for use in patients due to undergo certain imaging procedures. The device assesses kidney function by analysing a finger prick sample of blood for levels of creatinine, an indicator of a patient's renal function. Renal function of some patients, usually older patients or those with diabetes or kidney impairment, is a measure of their ability to safely receive IV contrast imaging agents prior to CT and MR imaging procedures. Currently, blood tests must be sent to a lab before the patient can undergo these. Waltham, Massachusetts-based Nova Biomedical, E-Z-EM's development partner for the analyser, gained US 510(k) clearance for the base technology, called StatSensor, in May.
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.